CASI Pharmaceuticals Acquires HBV ANDA from Laurus Labs Limited
CASI Pharmaceuticals, Inc. announces that it has acquired a U.S. FDA-approved abbreviated new drug application (ANDA) from Laurus Labs Limited. The drug, tenofovir disoproxil fumarate…
Read More...
Read More...
